LittelfuseIXSA80N120L2-7TRMOSFETs

Trans MOSFET N-CH SiC 1.2KV 79A 8-Pin(7+Tab) TO-263

Industrial grade, single switch SiC MOSFETs exhibiting good power cycling characteristics and very fast, low-losses switching behavior. These MOSFETs are recommended for use in high-speed industrial switch mode power supplies, solar inverters, high voltage DC/DC Converters, EV charging infrastructure, motor drives and induction heating.



Features

  • •  1200 V with low RDS(on) = 30 mΩ / 80
  • •  SiC MOSFET technology with -3/+15...+18 V gate drive
  • •  Low input capacitance of Ciss = 3000 pF
  • •  Maximum virtual junction temperature of Tvj = 175 ⁰C
  • •  Ultra-fast intrinsic body diode with trr = 54.8 ns / 25.6
  • •  Kelvin source connection


Benefits

  • •  Low conduction losses
  • •  Low gate drive power requirements
  • •  Low thermal management effort
  • •  Suitable for hard-switching
  • •  Optimized gate control


Applications

  • •  Solar inverters
  • •  UPS
  • •  High voltage DC/DC converters
  • •  Switch mode power Supplies
  • •  EV charging infrastructures
  • •  Motor drives
  • •  Induction heating
  • •  Industrial power Supply

Import TariffMay apply to this part

800 parts: Ships in 2 days

    Total$9.02Price for 1

    • Service Fee  $7.00

      Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2507+
      Manufacturer Lead Time:
      27 weeks
      Minimum Of :
      1
      Maximum Of:
      800
      Country Of origin:
      China
         
      • Price: $9.018
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2507+
      Manufacturer Lead Time:
      27 weeks
      Country Of origin:
      China
      • In Stock: 800 parts
      • Price: $9.018

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.